Skip to main content
Top
Published in: Infection 3/2020

Open Access 01-06-2020 | Vacuum Therapy | Review

Treatment of fracture-related infection of the lower extremity with antibiotic-eluting ceramic bone substitutes: case series of 35 patients and literature review

Authors: Sebastian Pesch, Marc Hanschen, Frederik Greve, Michael Zyskowski, Fritz Seidl, Chlodwig Kirchhoff, Peter Biberthaler, Stefan Huber-Wagner

Published in: Infection | Issue 3/2020

Login to get access

Abstract

Introduction

The current treatment concepts of fracture-related infection (FRI) [Consensus Conference (Anti-Infection Task Force (AITF)) on the definition of acute or chronic osteomyelitis (cOM)] are associated with unsolved challenges and problems, underlining the need for ongoing medical research.

Method

Literature review of treatments for FRI and description of own cases.

Results

We could include eight papers with 394 patients reporting treatments and outcome in FRI. The infection was resolved in 92.9% (mean) of all treatments. The mean follow-up was 25 months with a persistent non-union in 7% of the patients. We diagnosed 35 (19f/16m; 56.4 ± 18.6 years) patients with bone infections anatomically allocated to the proximal and distal femur (12×), the pelvis (2×), distal tibia (3×), tibial diaphysis (11×), the ankle joint (4×) and calcaneus (3×). These 35 patients were treated (1) with surgical debridement; (2) with antibiotic-eluting ceramic bone substitutes; (3) bone stabilization (including nail fixation, arthrodesis nails, plates, or external ring fixation), (4) optionally negative pressure wound therapy (NPWT) and (5) optionally soft tissue closure with local or free flaps. The mean follow-up time was 14.9 ± 10.6 months (min/max: 2/40 month). The overall recurrence rate is low (8.5%, 3/35). Prolonged wound secretion was observed in six cases (17.1%, 6/35). The overall number of surgeries was a median of 2.5.

Conclusion

The results in the literature and in our case series are explicitly promising regarding the treatment of posttraumatic fracture-related infection.
Literature
1.
go back to reference Yuste J, et al. Iliac bone Candida albicans osteomyelitis in a patient with iliac crest bone autograft: a case report and review of the literature. Infection. 2012;40:445–9.CrossRefPubMed Yuste J, et al. Iliac bone Candida albicans osteomyelitis in a patient with iliac crest bone autograft: a case report and review of the literature. Infection. 2012;40:445–9.CrossRefPubMed
2.
go back to reference Chan J, et al. First report of chronic implant-related septic arthritis and osteomyelitis due to Kytococcus schroeteri and a review of human K. schroeteri infections. Infections. 2012;40:567–73.CrossRef Chan J, et al. First report of chronic implant-related septic arthritis and osteomyelitis due to Kytococcus schroeteri and a review of human K. schroeteri infections. Infections. 2012;40:567–73.CrossRef
3.
go back to reference McLeod N, Fisher M, Rocco Lasala P. Vertebral osteomyelitis due to Candida species. Infection. 2019;47(3):475–8.CrossRefPubMed McLeod N, Fisher M, Rocco Lasala P. Vertebral osteomyelitis due to Candida species. Infection. 2019;47(3):475–8.CrossRefPubMed
4.
go back to reference Metsemakers W, et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury. 2018;49:511–22.CrossRefPubMed Metsemakers W, et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury. 2018;49:511–22.CrossRefPubMed
5.
go back to reference Thakore RV, et al. Surgical site infection in orthopedic trauma: a case–control study evaluating risk factors and cost. J Clin Orthopaedics Trauma. 2015;6:220–6.CrossRef Thakore RV, et al. Surgical site infection in orthopedic trauma: a case–control study evaluating risk factors and cost. J Clin Orthopaedics Trauma. 2015;6:220–6.CrossRef
6.
go back to reference Metsemakers W, et al. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505–10.CrossRefPubMed Metsemakers W, et al. Fracture-related infection: a consensus on definition from an international expert group. Injury. 2018;49:505–10.CrossRefPubMed
8.
go back to reference Bose D, et al. Management of infected nonunion of the long bones by a multidisciplinary team. Bone Joint J. 2015;97:814–7.CrossRefPubMed Bose D, et al. Management of infected nonunion of the long bones by a multidisciplinary team. Bone Joint J. 2015;97:814–7.CrossRefPubMed
9.
go back to reference McNally M, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J. 2016;98:1289–96.CrossRefPubMed McNally M, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J. 2016;98:1289–96.CrossRefPubMed
10.
go back to reference Ferguson J, Diefenbeck M, McNally M. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Joint Infect. 2017;2:38.CrossRef Ferguson J, Diefenbeck M, McNally M. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Joint Infect. 2017;2:38.CrossRef
11.
go back to reference Perlepe V, et al. Value of a radiographic score for the assessment of healing of nailed femoral and tibial shaft fractures: a retrospective preliminary study. Eur J Radiol. 2018;98:36–40.CrossRefPubMed Perlepe V, et al. Value of a radiographic score for the assessment of healing of nailed femoral and tibial shaft fractures: a retrospective preliminary study. Eur J Radiol. 2018;98:36–40.CrossRefPubMed
12.
go back to reference Ferguson J, et al. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014;96:829–36.CrossRefPubMed Ferguson J, et al. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014;96:829–36.CrossRefPubMed
13.
go back to reference Yamashita Y, et al. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthopaedics. 1998;22:247–51.CrossRef Yamashita Y, et al. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthopaedics. 1998;22:247–51.CrossRef
14.
go back to reference Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Disease Rep. 2008;10:394–403.CrossRef Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Disease Rep. 2008;10:394–403.CrossRef
15.
go back to reference Metsemakers W-J, et al. Infection after fracture fixation of the tibia: analysis of healthcare utilization and related costs. Injury. 2017;48:1204–10.CrossRefPubMed Metsemakers W-J, et al. Infection after fracture fixation of the tibia: analysis of healthcare utilization and related costs. Injury. 2017;48:1204–10.CrossRefPubMed
16.
go back to reference Willey M, Karam MJOC. Impact of infection on fracture fixation. Orthopedic Clin. 2016;47:357–64. Willey M, Karam MJOC. Impact of infection on fracture fixation. Orthopedic Clin. 2016;47:357–64.
17.
go back to reference Borrelli J, Prickett WD, Ricci WM. Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin Orthop Relat Res. 2003;411:245–54.CrossRef Borrelli J, Prickett WD, Ricci WM. Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin Orthop Relat Res. 2003;411:245–54.CrossRef
18.
go back to reference McNally M, et al. A comparative study of three bioabsorbable antibiotic carriers in chronic osteomyelitis: 313 patients with minimum one-year follow-up. Bone Joint J. 2015;97:21–21.CrossRef McNally M, et al. A comparative study of three bioabsorbable antibiotic carriers in chronic osteomyelitis: 313 patients with minimum one-year follow-up. Bone Joint J. 2015;97:21–21.CrossRef
19.
go back to reference Dijkman BG, et al. When is a fracture healed? Radiogr Clin Criteria Rev. 2010;24:S76–S80. Dijkman BG, et al. When is a fracture healed? Radiogr Clin Criteria Rev. 2010;24:S76–S80.
20.
go back to reference Kooistra BW, et al. The radiographic union scale in tibial fractures: reliability and validity. J Orthopaedic Trauma. 2010;24:S81–S8686.CrossRef Kooistra BW, et al. The radiographic union scale in tibial fractures: reliability and validity. J Orthopaedic Trauma. 2010;24:S81–S8686.CrossRef
21.
go back to reference Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006;37:S59–S66.CrossRefPubMed Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006;37:S59–S66.CrossRefPubMed
23.
go back to reference Kanakaris N, et al. The treatment of intramedullary osteomyelitis of the femur and tibia using the reamer–irrigator–aspirator system and antibiotic cement rods. Bone Joint J. 2014;96:783–8.CrossRefPubMed Kanakaris N, et al. The treatment of intramedullary osteomyelitis of the femur and tibia using the reamer–irrigator–aspirator system and antibiotic cement rods. Bone Joint J. 2014;96:783–8.CrossRefPubMed
24.
go back to reference Franceschini M, et al. Treatment of a chronic recurrent fistulized tibial osteomyelitis: administration of a novel antibiotic-loaded bone substitute combined with a pedicular muscle flap sealing. Eur J Orthopaedic Surg Traumatol. 2012;22:245–9.CrossRef Franceschini M, et al. Treatment of a chronic recurrent fistulized tibial osteomyelitis: administration of a novel antibiotic-loaded bone substitute combined with a pedicular muscle flap sealing. Eur J Orthopaedic Surg Traumatol. 2012;22:245–9.CrossRef
25.
go back to reference McKee MD, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthopaedic Trauma. 2010;24:483–90.CrossRef McKee MD, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthopaedic Trauma. 2010;24:483–90.CrossRef
26.
go back to reference McKee MD, et al. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthopaedic Trauma. 2002;16:622–7.CrossRef McKee MD, et al. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthopaedic Trauma. 2002;16:622–7.CrossRef
Metadata
Title
Treatment of fracture-related infection of the lower extremity with antibiotic-eluting ceramic bone substitutes: case series of 35 patients and literature review
Authors
Sebastian Pesch
Marc Hanschen
Frederik Greve
Michael Zyskowski
Fritz Seidl
Chlodwig Kirchhoff
Peter Biberthaler
Stefan Huber-Wagner
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01418-3

Other articles of this Issue 3/2020

Infection 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.